Due to the very stochastic nature, I think more trials on the evaluation seeds would mitigate the strongly varying results. So just resubmitting the same agent may yield in much better or much worse performance.
Due to the very stochastic nature, I think more trials on the evaluation seeds would mitigate the strongly varying results. So just resubmitting the same agent may yield in much better or much worse performance.